C.M. Capital Advisors
C.M. Capital Advisors, founded in 2007 and based in Palo Alto, California, is a registered investment adviser that operates as a subsidiary of C.M. Capital Corporation. The firm provides investment advisory services to institutional-class investors, focusing on enhancing returns through alternative asset classes such as venture capital, private equity, hedge funds, and real estate. C.M. Capital Advisors manages a multi-generational family office, advising a global family while also engaging in direct investments in both public and private companies. The firm's executive management team oversees the assets under management, fostering partnerships with clients and investment partners to optimize investment outcomes.
Tuya is a global developer platform specializing in artificial intelligence and the Internet of Things (IoT). It connects consumers, manufacturers, OEMs, and retail chains, providing a comprehensive solution that includes hardware access, cloud services, and app development. This ecosystem enables businesses to enhance their consumer IoT smart devices and meet increasing consumer demands. As of late 2018, Tuya had served 93,000 customers and connected over 100 million smart products globally, with a product catalog exceeding 30,000 listings across nearly 200 countries. The company operates a distributed IoT cloud platform that processes nearly 50 billion device requests daily and facilitates over 20 million voice AI interactions each day, accumulating a data volume of 15 petabytes. Tuya's offerings include platform-as-a-service and software-as-a-service options, fostering a vibrant IoT ecosystem that encourages collaboration among brands, OEMs, partners, and end users.
Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in liquid biopsy tests and analytics for cancer detection and treatment. The company provides advanced testing solutions, including Guardant360, a molecular diagnostic test that analyzes numerous cancer-related genes, and GuardantOMNI, which offers a comprehensive gene panel for immuno-oncology research. Additionally, Guardant Health has developed LUNAR-1 for detecting minimal residual disease in cancer survivors and is working on LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical companies and medical institutions by offering companion diagnostic development, clinical trial referrals, and liquid biopsy testing services. Guardant Health's innovations aim to address unmet needs in oncology and enhance patient health through advanced technology and research collaborations. The company was incorporated in 2011 and continues to lead in liquid-based cancer testing for both clinical and research applications.
Branch is a technology company that specializes in deep linking solutions aimed at enhancing user acquisition and retention for mobile applications. Founded in 2014 and based in Redwood City, California, Branch offers a suite of features that facilitate user-to-user referral programs, including rewarded referrals and content sharing. Its technology simplifies the app discovery process and personalizes user experiences through deep views, download banners, and tailored onboarding. Additionally, Branch provides a free software development kit (SDK) for deep linking, attribution, and mobile analytics, making it easier for developers to integrate these capabilities into their applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.